Schmidt-Habelmann P, Meisner H, Struck E, Sebening F
Thorac Cardiovasc Surg. 1981 Jun;29(3):155-7. doi: 10.1055/s-2007-1023466.
Sixteen patients, 8 males and 8 females were referred for surgery with the diagnosis of Ebstein's malformation of the tricuspid valve. The intervention was necessary because of deterioration of the clinical status. The age of the patients at the time of surgery ranged from 4 to 51 years. In 11 patients valvuloplasty was performed, in 5 patients the tricuspid valve was replaced with a bioprosthesis. One patient, with end-stage disease prior to surgery, died 2 days postoperatively rendering total mortality at 6.25%. Subsequent follow-up ranging from 8 months to 8 years was uneventful in the 15 survivors. Only 2 patients showed evidence of dysrhythmias, and demonstrated cardiothoracic ratios greater than 0.65. Cardiac catheterization in 3 patients, at one or 5 months postoperatively revealed normal pressure in the right heart. Provided the anterior tricuspid leaflet is of adequate size, surgical repair of Ebstein's anomaly through valvuloplasty appears to be feasible. The valvuloplasty consists of forming a monocusp valve with the anterior leaflet and plicating the atrialized portion of the right ventricle.
16例患者（8例男性，8例女性）因诊断为三尖瓣埃布斯坦畸形而接受手术治疗。由于临床状况恶化，手术干预是必要的。手术时患者年龄在4至51岁之间。11例患者接受了瓣膜成形术，5例患者用生物假体置换了三尖瓣。1例患者在手术前处于终末期疾病状态，术后2天死亡，总死亡率为6.25%。15名幸存者随后8个月至8年的随访情况良好。只有2例患者有心律失常的证据，心胸比率大于0.65。3例患者在术后1个月或5个月进行心导管检查，结果显示右心压力正常。如果三尖瓣前叶大小足够，通过瓣膜成形术对埃布斯坦畸形进行手术修复似乎是可行的。瓣膜成形术包括用前叶形成单叶瓣膜并折叠右心室的心房化部分。
